AIM ImmunoTech is trading at $0.30 (8.9%) up in after-hours trading, extending a multi-day rebound fueled by broader biotech sector strength and speculative interest.
- The stock has maintained upward momentum for several days despite a lack of specific company-related news or catalysts.
- The sharp price move may be partially attributed to thin after-hours liquidity, which can often amplify volatility during extended trading sessions.